Director, Neuromodulation Research Clinic, Douglas Institute
Psychiatrist, Depressive Disorders Program, Douglas Institute
Assistant Professor, Department of Psychiatry, McGill University
Clinical Research Scholar, Fonds de recherche du Québec – Santé (FRQS)
Expertise: Treatment-resistant depression, suicidality, neuromodulation, repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), deep transcranial magnetic stimulation (DTMS), neuroimaging, functional magnetic resonance imaging (fMRI)
Marcelo Berlim, MD, MSc, did his medical and psychiatric training and earned his master’s degree in Brazil. He then did a two-year clinical and research fellowship in depressive disorders at the Douglas Institute and McGill University. In 2012, Marcelo Berlim and Frederique Van den Eynde, MD, PhD founded the Neuromodulation Research Clinic at the Douglas Institute.
Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with state-of-the-art neuromodulation or brain stimulation techniques, including:
- repetitive transcranial magnetic stimulation [rTMS];
- transcranial direct current stimulation [tDCS];
- deep transcranial magnetic stimulation [DTMS].
He also uses neuromodulation approaches and brain imaging for investigating the neurobiological and neuropsychological bases of well-known predisposing factors for suicidal behaviour, namely decision-making deficits and heightened impulsivity.
Finally, Marcelo Berlim collaborates with other researchers at the Douglas Institute in studies that use neuromodulation techniques as treatments for schizophrenia and eating disorders.
Overall, his studies could lead to the development of new approaches for understanding and treating disabling psychiatric conditions including major depression, suicidality and schizophrenia.